Picture of Intelgenx Technologies logo

IGX Intelgenx Technologies Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual cashflow statement for Intelgenx Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-10.7-7.04-9.31-10.7-9.93
Depreciation
Deferred Taxes
Non-Cash Items1.190.4180.6650.4510.311
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.5550.1240.689-0.0542.33
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-8.2-5.77-7.17-9.52-6.53
Capital Expenditures-0.525-0.12-0.108-0.271-0.18
Purchase of Fixed Assets
Other Investing Cash Flow Items3.73-0.406-4.973.781.35
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities3.21-0.526-5.073.511.17
Financing Cash Flow Items0-0.451-0.4850-0.335
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.696.2415.52.966.78
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.48-0.1272.74-2.731.07